TABLE 5.
Activities of SSAT and ODC in the intestinal epithelia of animals treated with CGC-11157 for various timesa
Treatment | Activity (nmol/min/mg protein) ± SD
|
ODC/SSAT ratio | |
---|---|---|---|
SSAT | ODC | ||
Control | 0.033 ± 0.013 | 0.049 ± 0.022 | 1.48 |
i.p., 48 h | 0.081 ± 0.026 | 0.079 ± 0.047 | 0.97 |
i.p., 72 h | 0.034 ± 0.011 | 0.034 ± 0.011 | 1.00 |
i.p., 96 h | 0.040 ± 0.015 | 0.160 ± 0.169 | 4.00 |
p.o., 48 h | 0.090 ± 0.016 | 0.089 ± 0.070 | 0.99 |
p.o., 72 h | 0.036 ± 0.010 | 0.056 ± 0.029 | 1.55 |
p.o., 96 h | 0.040 ± 0.014 | 0.116 ± 0.048 | 2.90 |
Dosing was once per day. i.p. indicates 0.2 mg of CGC-11157 administered via intraperitoneal injection; p.o. indicates 2 mg of CGC-11157 administered per os.